Correlation between clinical and laboratorial findings of the leprosy cases followed at the "Alfredo da Matta" Dermatology Center, Manaus-AM, Brazil, from January 2000 to March 2001, based on secondary data;Correlação clínico-laboratorial baseada em dados secundários dos casos de hanseníase atendidos no período de 01/2000 a 03/2001 na Fundação Alfredo da Matta, Manaus-AM, Brasil*

Anais Brasileiros de Dermatologia

Volumn 79, Issue 5, 2004, Pages 547-554

  Crippa, Iara L F ^a,b   Schettini, Maria Conceição ^a   Schettini, Antonio P ^a,b   Bessa Rebello, Paula F ^a,b   Pennini, Silmara N ^a,b  

^a Fundação Alfredo da Matta

^b Patologia Tropical ^*

Author keywords

Leprosy; Leprosy classification; Sensitivity; Specificity

Indexed keywords

EID: 33846821452     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/S0365-05962004000500004     Document Type: Article

References (14)

1. World Health Organization. Chemoterapy of leprosy for control programmes. WHO Technical report Series nr. 874, Geneva, 1998.
2. Andrade V LG, Moreira TA, Avelleira JCR, Marques AB, Bayona, M. Paucibacilar ou multibacilar? Uma contribuição para os serviços de saúde. Hans Int 1996;21:6-13.
3. Ministério da Saúde do Brasil. Secretaria de Políticas de Saúde. Coordenação Nacional de Dermatologia Sanitária. Guia para o controle da Hanseníase-1993, Brasília.
4. Ministério da Saúde do Brasil. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Área Técnica de Dermatologia Sanitária. Legislação sobre o controle da Hanseníase no Brasil-2000, Brasília.
5. Ministério da Saúde do Brasil. Secretaria de Políticas de Saúde. Departamento de Atenção Básica. Guia para o controle da Hanseníase-2002, Brasília.
6. Opromolla DVA. Clínica da Hanseníase. Hans Int. 2001; 26:1-4.
7. Becx-Bleumink M. Allocation of pacients to paucibacillary or multibacillary drug regimenens for the treatment of leprosy - a comparison of methods based mainly on skin smears as opposed to clinical methods for classification of patients. Int J Lepr. 1991; 59:292-303.
8. Van Brakel WH, Soldenhoff R, McDougall AC. The allocation of leprosy cases into paucibacillary and multibacillary groups for multidrug therapy taking into account the number of body areas a ffected by skin and nerve lesions. Lepr Rev. 1992;63:231-46.
9. Groenen G, Saha NG, Rashid MA, Hamid MA, Pattyn SR. Classification of leprosy cases under field conditions in Bangladesh. II. Realiability of clinical criteria. Lepr Rev. 1995;66:134-43.
10. Croft RP, Smith WC, Nicholls P, Richardus JH. Sensitivity and specificity of methods of classification of leprosy without use of skin-smear examination. Int J Lepr. 1998;66:445-50.
11. Dasananjali K, Schreuder PA, Pirayvaraporn C. A study on effectiveness and safety of the WHO/MDT regimen in the northeast of Thailand: a prospective study.1984-1996. Int J Lepr. 1997;5:28-36
12. Buhrer-Sékula S, Sarno EN, Oskam L et al. Use of ML dipstick as a tool to classify leprosy patients. Int J Lepr. 2001; 68:456-63.
13. The Diagnosis and Classification of Leprosy. Report of the international Leprosy Association Technical Forum. Int J Lepr. 2002;S23-S31.
14. a ed. Brasília: Editora Guanabara Koogan S. A. Rio de Janeiro, 1995. 583p.